MedPath

Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy

Not Applicable
Completed
Conditions
Prostate Cancer
Obesity
Interventions
Behavioral: Weight Loss Program
Behavioral: Standardized educational flyer
Behavioral: Weight Maintenance Program
Registration Number
NCT03261271
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The purpose of this study is to test how a weight management program affects substances in the blood called biomarkers that can show the presence or severity of cancer, compared to a standardized diet and exercise educational flyer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Men newly diagnosed with PCa who are scheduled for radical prostatectomy (RP) (T1 or T2)
  • Body Mass Index (BMI) 25-45 kg/m2
  • Has internet access
Exclusion Criteria
  • History of 5 alpha reductase inhibitors prior 3 months
  • History of radiation therapy for cancer treatment
  • Taking active cancer treatment
  • Undergoing salvage therapy
  • Castration-resistant PCa
  • Evidence of metastasis
  • Evidence of biochemical recurrence
  • High risk medical condition (e.g. kidney disease, uncontrolled diabetes, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Weight Loss and Weight MaintenanceWeight Loss ProgramParticipants will take part in a weight loss program for at least 4 weeks (and up to 16 weeks) before their prostatectomy, and a weight maintenance program for 6 months after their surgery.
Weight Loss and Weight MaintenanceWeight Maintenance ProgramParticipants will take part in a weight loss program for at least 4 weeks (and up to 16 weeks) before their prostatectomy, and a weight maintenance program for 6 months after their surgery.
ControlStandardized educational flyerParticipants will receive a standardized educational flyer about a healthy diet and exercise.
Primary Outcome Measures
NameTimeMethod
Impact of Weight Loss Before and Weight Maintenance After Prostate Cancer (PCa) Surgery on Immunosuppressive FactorsChange from Baseline to Month 6

Impact will be measured by changes in specific blood immune biomarker monocytic myeloid-derived suppressor cells (mMDSCs). The absolute number of cell counts were calculated using the lymphocyte count abstracted from the complete blood count with differential.

Secondary Outcome Measures
NameTimeMethod
Change in WeightChange from Baseline to Month 6

Body weight will be measured at participant study visits.

Impact of Weight Loss Before and Weight Maintenance After PCa Surgery on Inflammation FactorsChange from Baseline to Month 6

Impact will be measured by changes in specific blood biomarker leptin/adiponectin ratio.

Change in Body CompositionChange from Baseline to Study End

Body composition will be measured using a Dual Energy X-Ray Absorptiometry (iDXA). Change in percent body fat will be analyzed between groups from baseline to study end.

Change in Quality of LifeChange from Baseline to Month 6

Quality of Life will be measured using the Expanded PCa Index Composite (EPIC) Instrument-26. There are a total of 26 items on the survey. Scores range from 0 to 100. The higher the score, the higher the quality of life.

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath